Emmyon, Inc. is a biotechnology company based in Rochester, MN, specializing in metabolic health research. They focus on investigating the mechanisms behind muscle atrophy caused by aging, illness, and injury. Using this data, they develop small molecules that enhance muscle strength, mass, and metabolism.
One of Emmyon's patented technologies is Ursolic Acid and Tomatidine, which aids in maintaining normal muscle mass and strength. The company is dedicated to finding innovative solutions for muscle health in humans, pets, and production animals. They are at the forefront of creating natural feed additives and pharmaceuticals to combat muscle atrophy, obesity, and type 2 diabetes.
Emmyon's commitment to healthy aging extends to pioneering ways to preserve muscle quality and strength during the aging process. Their research also delves into developing products that enhance mobility and quality of life for pets, as well as improving feed additives for livestock production. Emmyon, Inc. continues to make strides in the field of metabolic health with a focus on skeletal muscle well-being.
Generated from the website content
